Cancer Medication Market-Global Outlook and Forecast 2021-2027

Cancer Medication Market-Global Outlook and Forecast 2021-2027

  • Market Monitor Global
  • August 2021
  • Pharmaceutical
  • 93 pages
1 Introduction to Research & Analysis Reports
1.1 Cancer Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Medication Overall Market Size
2.1 Global Cancer Medication Market Size: 2021 VS 2027
2.2 Global Cancer Medication Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Medication Players in Global Market
3.2 Top Global Cancer Medication Companies Ranked by Revenue
3.3 Global Cancer Medication Revenue by Companies
3.4 Top 3 and Top 5 Cancer Medication Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cancer Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Medication Players in Global Market
3.6.1 List of Global Tier 1 Cancer Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Medication Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Medication Market Size Markets, 2021 & 2027
4.1.2 Antimetabolite
4.1.3 Alkaloid Drugs
4.1.4 Hormone
4.1.5 Targeted Drug
4.1.6 Platinum-based Drugs
4.1.7 Other
4.2 By Type - Global Cancer Medication Revenue & Forecasts
4.2.1 By Type - Global Cancer Medication Revenue, 2016-2021
4.2.2 By Type - Global Cancer Medication Revenue, 2022-2027
4.2.3 By Type - Global Cancer Medication Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Medication Market Size, 2021 & 2027
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Castrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory/Lung Cancer
5.1.7 Other
5.2 By Application - Global Cancer Medication Revenue & Forecasts
5.2.1 By Application - Global Cancer Medication Revenue, 2016-2021
5.2.2 By Application - Global Cancer Medication Revenue, 2022-2027
5.2.3 By Application - Global Cancer Medication Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Cancer Medication Market Size, 2021 & 2027
6.2 By Region - Global Cancer Medication Revenue & Forecasts
6.2.1 By Region - Global Cancer Medication Revenue, 2016-2021
6.2.2 By Region - Global Cancer Medication Revenue, 2022-2027
6.2.3 By Region - Global Cancer Medication Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Cancer Medication Revenue, 2016-2027
6.3.2 US Cancer Medication Market Size, 2016-2027
6.3.3 Canada Cancer Medication Market Size, 2016-2027
6.3.4 Mexico Cancer Medication Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Cancer Medication Revenue, 2016-2027
6.4.2 Germany Cancer Medication Market Size, 2016-2027
6.4.3 France Cancer Medication Market Size, 2016-2027
6.4.4 U.K. Cancer Medication Market Size, 2016-2027
6.4.5 Italy Cancer Medication Market Size, 2016-2027
6.4.6 Russia Cancer Medication Market Size, 2016-2027
6.4.7 Nordic Countries Cancer Medication Market Size, 2016-2027
6.4.8 Benelux Cancer Medication Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Cancer Medication Revenue, 2016-2027
6.5.2 China Cancer Medication Market Size, 2016-2027
6.5.3 Japan Cancer Medication Market Size, 2016-2027
6.5.4 South Korea Cancer Medication Market Size, 2016-2027
6.5.5 Southeast Asia Cancer Medication Market Size, 2016-2027
6.5.6 India Cancer Medication Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Cancer Medication Revenue, 2016-2027
6.6.2 Brazil Cancer Medication Market Size, 2016-2027
6.6.3 Argentina Cancer Medication Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Medication Revenue, 2016-2027
6.7.2 Turkey Cancer Medication Market Size, 2016-2027
6.7.3 Israel Cancer Medication Market Size, 2016-2027
6.7.4 Saudi Arabia Cancer Medication Market Size, 2016-2027
6.7.5 UAE Cancer Medication Market Size, 2016-2027
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Cancer Medication Major Product Offerings
7.1.4 Roche Cancer Medication Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 HENGRUI
7.2.1 HENGRUI Corporate Summary
7.2.2 HENGRUI Business Overview
7.2.3 HENGRUI Cancer Medication Major Product Offerings
7.2.4 HENGRUI Cancer Medication Revenue in Global (2016-2021)
7.2.5 HENGRUI Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Cancer Medication Major Product Offerings
7.3.4 AstraZeneca Cancer Medication Revenue in Global (2016-2021)
7.3.5 AstraZeneca Key News
7.4 QILU
7.4.1 QILU Corporate Summary
7.4.2 QILU Business Overview
7.4.3 QILU Cancer Medication Major Product Offerings
7.4.4 QILU Cancer Medication Revenue in Global (2016-2021)
7.4.5 QILU Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Cancer Medication Major Product Offerings
7.5.4 Sanofi Cancer Medication Revenue in Global (2016-2021)
7.5.5 Sanofi Key News
7.6 HANSOH
7.6.1 HANSOH Corporate Summary
7.6.2 HANSOH Business Overview
7.6.3 HANSOH Cancer Medication Major Product Offerings
7.6.4 HANSOH Cancer Medication Revenue in Global (2016-2021)
7.6.5 HANSOH Key News
7.7 LUYE
7.7.1 LUYE Corporate Summary
7.7.2 LUYE Business Overview
7.7.3 LUYE Cancer Medication Major Product Offerings
7.4.4 LUYE Cancer Medication Revenue in Global (2016-2021)
7.7.5 LUYE Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Cancer Medication Major Product Offerings
7.8.4 Novartis Cancer Medication Revenue in Global (2016-2021)
7.8.5 Novartis Key News
7.9 GuiZhou YiBai
7.9.1 GuiZhou YiBai Corporate Summary
7.9.2 GuiZhou YiBai Business Overview
7.9.3 GuiZhou YiBai Cancer Medication Major Product Offerings
7.9.4 GuiZhou YiBai Cancer Medication Revenue in Global (2016-2021)
7.9.5 GuiZhou YiBai Key News
7.10 Lunan
7.10.1 Lunan Corporate Summary
7.10.2 Lunan Business Overview
7.10.3 Lunan Cancer Medication Major Product Offerings
7.10.4 Lunan Cancer Medication Revenue in Global (2016-2021)
7.10.5 Lunan Key News
7.11 Eli Lilly and Company
7.11.1 Eli Lilly and Company Corporate Summary
7.11.2 Eli Lilly and Company Business Overview
7.11.3 Eli Lilly and Company Cancer Medication Major Product Offerings
7.11.4 Eli Lilly and Company Cancer Medication Revenue in Global (2016-2021)
7.11.5 Eli Lilly and Company Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Cancer Medication Market Opportunities & Trends in Global Market
Table 2. Cancer Medication Market Drivers in Global Market
Table 3. Cancer Medication Market Restraints in Global Market
Table 4. Key Players of Cancer Medication in Global Market
Table 5. Top Cancer Medication Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cancer Medication Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cancer Medication Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cancer Medication Product Type
Table 9. List of Global Tier 1 Cancer Medication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Medication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type Global Cancer Medication Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cancer Medication Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cancer Medication Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application Global Cancer Medication Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cancer Medication Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cancer Medication Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region Global Cancer Medication Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cancer Medication Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cancer Medication Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cancer Medication Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cancer Medication Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cancer Medication Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cancer Medication Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cancer Medication Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cancer Medication Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cancer Medication Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cancer Medication Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cancer Medication Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cancer Medication Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Cancer Medication Product Offerings
Table 32. Roche Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 33. HENGRUI Corporate Summary
Table 34. HENGRUI Cancer Medication Product Offerings
Table 35. HENGRUI Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Cancer Medication Product Offerings
Table 38. AstraZeneca Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 39. QILU Corporate Summary
Table 40. QILU Cancer Medication Product Offerings
Table 41. QILU Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Cancer Medication Product Offerings
Table 44. Sanofi Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 45. HANSOH Corporate Summary
Table 46. HANSOH Cancer Medication Product Offerings
Table 47. HANSOH Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 48. LUYE Corporate Summary
Table 49. LUYE Cancer Medication Product Offerings
Table 50. LUYE Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 51. Novartis Corporate Summary
Table 52. Novartis Cancer Medication Product Offerings
Table 53. Novartis Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 54. GuiZhou YiBai Corporate Summary
Table 55. GuiZhou YiBai Cancer Medication Product Offerings
Table 56. GuiZhou YiBai Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 57. Lunan Corporate Summary
Table 58. Lunan Cancer Medication Product Offerings
Table 59. Lunan Cancer Medication Revenue (US$, Mn), (2016-2021)
Table 60. Eli Lilly and Company Corporate Summary
Table 61. Eli Lilly and Company Cancer Medication Product Offerings
Table 62. Eli Lilly and Company Cancer Medication Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Cancer Medication Segment by Type
Figure 2. Cancer Medication Segment by Application
Figure 3. Global Cancer Medication Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Medication Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cancer Medication Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Medication Revenue in 2020
Figure 8. By Type - Global Cancer Medication Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cancer Medication Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cancer Medication Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cancer Medication Revenue Market Share, 2016-2027
Figure 12. US Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cancer Medication Revenue Market Share, 2016-2027
Figure 16. Germany Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 17. France Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cancer Medication Revenue Market Share, 2016-2027
Figure 24. China Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 28. India Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cancer Medication Revenue Market Share, 2016-2027
Figure 30. Brazil Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cancer Medication Revenue Market Share, 2016-2027
Figure 33. Turkey Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cancer Medication Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. HENGRUI Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. AstraZeneca Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. QILU Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sanofi Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. HANSOH Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. LUYE Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Novartis Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. GuiZhou YiBai Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Lunan Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Eli Lilly and Company Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Have query on this report?

Success Stories

Our Clients